The mammary gland response to estradiol: Monotonic at the cellular level, non-monotonic at the tissue-level of organization?

The role of hormones in mammary gland development has been studied in detail using surgical and genetic models. These studies have indicated roles for estrogen in ductal elongation and terminal end bud formation. However, no comprehensive study has quantified how different doses of estrogen affect morphological parameters of mammary gland development. Additionally, comparisons between the estrogen-responsiveness of the mammary gland and uterus, the model organ for estrogen action are incomplete. In this study, immature mice were ovariectomized and implanted with osmotic pumps releasing one of eight doses of 17beta-estradiol for 10 days. As expected from the classical uterotrophic assay, the uterus showed a monotonic dose-response curve for all measured endpoints. In contrast, the mammary gland showed a non-monotonic, inverted-U shaped response to estrogen with regard to morphometric parameters, and a monotonic response with regard to gene expression parameters. These results indicate that estrogen has opposing effects in mammary gland morphogenesis depending on estrogen dose, i.e. low to moderate doses induce terminal end bud formation and ductal elongation while higher doses inhibit these processes. This non-monotonic dose-response in the mammary gland may reflect complex interactions, where estrogen can act on multiple targets either as an agonist or antagonist.

[1]  N. Olea,et al.  Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response. , 1995, Oncology research.

[2]  J C Reed,et al.  Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. , 1996, Development.

[3]  P. Kelly,et al.  Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. , 1997, Genes & development.

[4]  C. Hughes,et al.  An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment , 2005, Environmental health perspectives.

[5]  A. Wärri,et al.  Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Sonnenschein,et al.  Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Ana M Soto,et al.  Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. , 2005, Endocrinology.

[8]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[9]  S. Nandi,et al.  Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse. , 1958, Journal of the National Cancer Institute.

[10]  J. Gustafsson,et al.  Estrogen receptors α and β in the rodent mammary gland , 2000, Breast Cancer Research.

[11]  B. Chilton,et al.  Differences in the rabbit uterine response to progesterone as influenced by growth hormone or prolactin. , 1987, Journal of reproduction and fertility.

[12]  Kristina A Thayer,et al.  Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.

[13]  E. Simpson,et al.  Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Colborn,et al.  Chemically-induced alterations in sexual and functional development : the wildlife/human connection , 1992 .

[15]  C. Mcgrath.  Augmentation of the response of normal mammary epithelial cells to estradiol by mammary stroma. , 1983, Cancer research.

[16]  N. Bruchovsky,et al.  Hormonal effects on cell proliferation in rat prostate. , 1975, Vitamins and hormones.

[17]  C Sonnenschein,et al.  The role of estrogens on the proliferation of human breast tumor cells (MCF-7). , 1985, Journal of steroid biochemistry.

[18]  R. Weinberg,et al.  Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. , 2000, Genes & development.

[19]  K. Korach,et al.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W D Pennie,et al.  Differential activation by xenoestrogens of ER alpha and ER beta when linked to different response elements. , 1998, The Journal of endocrinology.

[21]  T. Dale,et al.  Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. , 1994, Differentiation; research in biological diversity.

[22]  B. Groner,et al.  Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis. , 1992, Molecular endocrinology.

[23]  Ana M Soto,et al.  Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid‐hormone target organs , 2003, Evolution & development.

[24]  C. Watson,et al.  Xenoestrogens at Picomolar to Nanomolar Concentrations Trigger Membrane Estrogen Receptor-α–Mediated Ca2+ Fluxes and Prolactin Release in GH3/B6 Pituitary Tumor Cells , 2005, Environmental health perspectives.

[25]  N. Horseman.  Prolactin and Mammary Gland Development , 2004, Journal of Mammary Gland Biology and Neoplasia.

[26]  N. Olea,et al.  Negative controls of cell proliferation: human prostate cancer cells and androgens. , 1989, Cancer research.

[27]  C. Sonnenschein,et al.  Long-Term Effects of Fetal Exposure to Low Doses of the Xenoestrogen Bisphenol-A in the Female Mouse Genital Tract1 , 2005, Biology of reproduction.

[28]  G. R. Barrie Webster,et al.  Hormonally Active Agents in the Environment , 2001 .

[29]  J. Gustafsson,et al.  Estrogen receptors ER alpha and ER beta in proliferation in the rodent mammary gland. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Dey,et al.  Canonical Wnt signaling is critical to estrogen-mediated uterine growth. , 2004, Molecular endocrinology.

[31]  J. Lydon,et al.  Hormonal defect in maspin heterozygous mice reveals a role of progesterone in pubertal ductal development. , 2004, Molecular endocrinology.

[32]  J. Gustafsson,et al.  Expression of estrogen receptor alpha and beta during mouse embryogenesis , 1999, Mechanisms of Development.

[33]  P. Dannies,et al.  17β-ESTRADIOL HAS A BIPHASIC EFFECT ON GH CELL GROWTH1 , 1983 .

[34]  S. Haslam.  Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro. , 1986, Cancer research.

[35]  J. Škarda.  Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice. , 2002, Physiological research.

[36]  J. King,et al.  Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. , 2001, Environmental health perspectives.

[37]  B. O’Malley,et al.  Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus. , 1998, Biology of reproduction.

[38]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[39]  R. Newbold.  The Mouse Uterotrophic Assay: Other End Points , 2001, Environmental health perspectives.

[40]  C. Sonnenschein,et al.  Identification of human estrogen-inducible transcripts that potentially mediate the apoptotic response in breast cancer , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  L. Martin,et al.  Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study. , 1973, The Journal of endocrinology.

[42]  C. Sonnenschein,et al.  In Utero Exposure to Bisphenol A Alters the Development and Tissue Organization of the Mouse Mammary Gland , 2001 .

[43]  A. Kortenkamp,et al.  Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. , 2002, Environmental science & technology.

[44]  E. Desombre,et al.  Modulation of uterine morphology and growth by estradiol-17beta and an estrogen antagonist , 1975, The Journal of cell biology.

[45]  C. Teng,et al.  Differential Expression and Estrogen Response of Lactoferrin Gene in the Female Reproductive Tract of Mouse, Rat, and Hamster , 2002, Biology of reproduction.

[46]  P. Chambon,et al.  Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Kevin W. Gaido,et al.  Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol , 1998, Molecular and Cellular Endocrinology.

[48]  R. Newbold,et al.  Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. , 2001, Reproductive toxicology.

[49]  S. Ball,et al.  The development of the terminal end bud in the prepubertal‐pubertal mouse mammary gland , 1998, The Anatomical record.

[50]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[51]  J. Gorski,et al.  Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis. , 1976, Endocrinology.

[52]  S. Haslam.  The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. , 1989, Endocrinology.

[53]  C. Sonnenschein,et al.  Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[54]  C. Sonnenschein,et al.  The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. , 2000, Environmental health perspectives.

[55]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  E. Haag.  Meeting Review: the Microevolution of Development , 2003, Evolution & development.

[57]  J. Gorski,et al.  A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. , 1981, Endocrinology.

[58]  J. K. Day,et al.  Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high doses. , 2002, Toxicology and applied pharmacology.

[59]  B. Vonderhaar,et al.  Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. , 1987, Cancer research.

[60]  V. Jordan,et al.  Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen. , 1980, Endocrinology.

[61]  C Sonnenschein,et al.  The two faces of janus: sex steroids as mediators of both cell proliferation and cell death. , 2001, Journal of the National Cancer Institute.

[62]  H. Bern,et al.  Long-term effects of perinatal exposure to hormones on normal and neoplastic mammary growth in rodents: a review. , 1979, Journal of environmental pathology and toxicology.

[63]  K. Korach,et al.  Mammary Gland Development and Tumorigenesis in Estrogen Receptor Knockout Mice , 1997, Journal of Mammary Gland Biology and Neoplasia.

[64]  C. Daniel,et al.  Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions. , 1996, Developmental biology.

[65]  S. Miettinen,et al.  Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[66]  K. Coser,et al.  Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Conolly,et al.  Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  P. Kelly,et al.  Mammary Gland Development in Prolactin Receptor Knockout Mice , 1997, Journal of Mammary Gland Biology and Neoplasia.

[69]  C. Sonnenschein,et al.  Cell proliferation of estrogen-sensitive cells: the case for negative control. , 1987, Endocrine reviews.